Literature DB >> 33478504

Ten-year cardiovascular risk in diabetes patients without obstructive coronary artery disease: a retrospective Western Denmark cohort study.

Kevin Kris Warnakula Olesen1,2,3, Morten Madsen4, Christine Gyldenkerne5, Pernille Gro Thrane5, Troels Thim5, Lisette Okkels Jensen6, Hans Erik Bøtker5, Henrik Toft Sørensen4, Michael Maeng5.   

Abstract

BACKGROUND: Diabetes patients without obstructive coronary artery disease as assessed by coronary angiography have a low risk of myocardial infarction, but their myocardial infarction risk may still be higher than the general population. We examined the 10-year risks of myocardial infarction, ischemic stroke, and death in diabetes patients without obstructive coronary artery disease according to coronary angiography, compared to risks in a matched general population cohort.
METHODS: We included all diabetes patients without obstructive coronary artery disease examined by coronary angiography from 2003 to 2016 in Western Denmark. Patients were matched by age and sex with a cohort from the Western Denmark general population without a previous myocardial infarction or coronary revascularization. Outcomes were myocardial infarction, ischemic stroke, and death. Ten-year cumulative incidences were computed. Adjusted hazard ratios (HR) then were computed using stratified Cox regression with the general population as reference.
RESULTS: We identified 5734 diabetes patients without obstructive coronary artery disease and 28,670 matched individuals from the general population. Median follow-up was 7 years. Diabetes patients without obstructive coronary artery disease had an almost similar 10-year risk of myocardial infarction (3.2% vs 2.9%, adjusted HR 0.93, 95% CI 0.72-1.20) compared to the general population, but had an increased risk of ischemic stroke (5.2% vs 2.2%, adjusted HR 1.87, 95% CI 1.47-2.38) and death (29.6% vs 17.8%, adjusted HR 1.24, 95% CI 1.13-1.36).
CONCLUSIONS: Patients with diabetes and no obstructive coronary artery disease have a 10-year risk of myocardial infarction that is similar to that found in the general population. However, they still remain at increased risk of ischemic stroke and death.

Entities:  

Keywords:  Coronary angiography; Coronary artery disease; Death; Diabetes; Ischemic stroke; Myocardial infarction

Year:  2021        PMID: 33478504      PMCID: PMC7819163          DOI: 10.1186/s12933-021-01212-x

Source DB:  PubMed          Journal:  Cardiovasc Diabetol        ISSN: 1475-2840            Impact factor:   9.951


  40 in total

1.  Nonobstructive coronary artery disease and risk of myocardial infarction.

Authors:  Thomas M Maddox; Maggie A Stanislawski; Gary K Grunwald; Steven M Bradley; P Michael Ho; Thomas T Tsai; Manesh R Patel; Amneet Sandhu; Javier Valle; David J Magid; Benjamin Leon; Deepak L Bhatt; Stephan D Fihn; John S Rumsfeld
Journal:  JAMA       Date:  2014-11-05       Impact factor: 56.272

2.  A modified poisson regression approach to prospective studies with binary data.

Authors:  Guangyong Zou
Journal:  Am J Epidemiol       Date:  2004-04-01       Impact factor: 4.897

3.  Coronary computed tomography angiography as a tool for long-term cardiovascular risk stratification in diabetic patients.

Authors:  Tom Finck; Albrecht Will; Eva Hendrich; Stefan Martinoff; Martin Hadamitzky
Journal:  Heart Vessels       Date:  2019-01-11       Impact factor: 2.037

4.  Prognostic value of nonobstructive and obstructive coronary artery disease detected by coronary computed tomography angiography to identify cardiovascular events.

Authors:  Marcio Sommer Bittencourt; Edward Hulten; Brian Ghoshhajra; Daniel O'Leary; Mitalee P Christman; Philip Montana; Quynh A Truong; Michael Steigner; Venkatesh L Murthy; Frank J Rybicki; Khurram Nasir; Luis Henrique W Gowdak; Jon Hainer; Thomas J Brady; Marcelo F Di Carli; Udo Hoffmann; Suhny Abbara; Ron Blankstein
Journal:  Circ Cardiovasc Imaging       Date:  2014-02-18       Impact factor: 7.792

5.  Comparison of Frequency of Ischemic Stroke in Patients With Versus Without Coronary Heart Disease and Without Atrial Fibrillation.

Authors:  Kevin Kris Warnakula Olesen; Kamilla Steensig; Morten Madsen; Troels Thim; Lisette Okkels Jensen; Bent Raungaard; John Eikelboom; Steen Dalby Kristensen; Hans Erik Bøtker; Michael Maeng
Journal:  Am J Cardiol       Date:  2018-09-26       Impact factor: 2.778

Review 6.  Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis.

Authors:  Alka M Kanaya; Deborah Grady; Elizabeth Barrett-Connor
Journal:  Arch Intern Med       Date:  2002 Aug 12-26

7.  Evaluation of algorithms for registry-based detection of acute myocardial infarction following percutaneous coronary intervention.

Authors:  Gro Egholm; Morten Madsen; Troels Thim; Morten Schmidt; Evald Høj Christiansen; Hans Erik Bøtker; Michael Maeng
Journal:  Clin Epidemiol       Date:  2016-10-19       Impact factor: 4.790

8.  Association of Isolated Coronary Microvascular Dysfunction With Mortality and Major Adverse Cardiac Events: A Systematic Review and Meta-Analysis of Aggregate Data.

Authors:  Mark A Gdowski; Venkatesh L Murthy; Michelle Doering; Andrea G Monroy-Gonzalez; Riemer Slart; David L Brown
Journal:  J Am Heart Assoc       Date:  2020-04-29       Impact factor: 5.501

9.  Duration of type 2 diabetes mellitus and systolic blood pressure as determinants of severity of coronary stenosis and adverse events in an asymptomatic diabetic population: PROCEED study.

Authors:  Shreenidhi M Venuraju; Avijit Lahiri; Anand Jeevarethinam; Mark Cohen; Daniel Darko; Devaki Nair; Miranda Rosenthal; Roby D Rakhit
Journal:  Cardiovasc Diabetol       Date:  2019-04-23       Impact factor: 9.951

Review 10.  Glycated haemoglobin A1c as a risk factor of cardiovascular outcomes and all-cause mortality in diabetic and non-diabetic populations: a systematic review and meta-analysis.

Authors:  Iván Cavero-Redondo; Barbara Peleteiro; Celia Álvarez-Bueno; Fernando Rodriguez-Artalejo; Vicente Martínez-Vizcaíno
Journal:  BMJ Open       Date:  2017-07-31       Impact factor: 2.692

View more
  4 in total

1.  A randomised controlled trial to assess the antithrombotic effects of aspirin in type 1 diabetes: role of dosing and glycaemic control.

Authors:  Robert F Storey; Ramzi A Ajjan; William A E Parker; Rebecca Sagar; Zeyad Kurdee; Fladia Hawkins; Khalid M Naseem; Peter J Grant
Journal:  Cardiovasc Diabetol       Date:  2021-12-17       Impact factor: 8.949

2.  Impact of diabetes on long-term all-cause re-hospitalization after revascularization with percutaneous coronary intervention.

Authors:  Kirstine N Hansen; Manijeh Noori; Evald H Christiansen; Eskild B Kristiansen; Michael Maeng; Ann Dorthe O Zwisler; Britt Borregaard; Rikke Søgaard; Karsten T Veien; Anders Junker; Lisette Okkels Jensen
Journal:  Diab Vasc Dis Res       Date:  2022 Jul-Aug       Impact factor: 3.541

3.  CT-Based Leiden Score Outperforms Confirm Score in Predicting Major Adverse Cardiovascular Events for Diabetic Patients with Suspected Coronary Artery Disease.

Authors:  Zinuan Liu; Yipu Ding; Guanhua Dou; Xi Wang; Dongkai Shan; Bai He; Jing Jing; Yundai Chen; Junjie Yang
Journal:  Korean J Radiol       Date:  2022-09-05       Impact factor: 7.109

4.  Clinical Characteristics Predicting Worse Long-Term Outcomes in Patients with Myocardial Infarction and Non-Obstructive Coronary Arteries (MINOCA).

Authors:  Piotr Szolc; Łukasz Niewiara; Paweł Kleczyński; Krzysztof Bryniarski; Elżbieta Ostrowska-Kaim; Kornelia Szkodoń; Piotr Brzychczy; Krzysztof Żmudka; Jacek Legutko; Bartłomiej Guzik
Journal:  J Cardiovasc Dev Dis       Date:  2022-08-26
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.